These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30143452)

  • 21. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
    Zhang X; He H; Zhang X; Guo W; Wang Y
    Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.
    Li YS; Xie Q; Yang DY; Zheng Y
    Mol Biol Rep; 2014 Jun; 41(6):3925-33. PubMed ID: 24566681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
    Yu H; Wang Y; Wang S; Sun N
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
    Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
    Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
    Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
    Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma: a meta-analysis].
    Zhang LH; Zhang CY; Dai XZ; Zhang J; Zhang F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):749-754. PubMed ID: 29108203
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.
    Xiao X; Cai F; Niu X; Shi H; Zhong Y
    PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu Y; Li L; Xiang X; Wang H; Cai W; Xie J; Han Y; Bao S; Xie Q
    Gene; 2013 Sep; 527(2):584-93. PubMed ID: 23791656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas.
    Herath NI; Kew MC; Walsh MD; Young J; Powell LW; Leggett BA; MacDonald GA
    J Gastroenterol Hepatol; 2002 Mar; 17(3):301-7. PubMed ID: 11982701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu YZ; Zhu R; Fan J; Pan Q; Li H; Chen Q; Zhu HG
    J Viral Hepat; 2010 Feb; 17(2):98-107. PubMed ID: 19732323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
    Li Q; Li B; Dong C; Wang Y; Li Q
    Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma.
    Zhou Y; Qiu XP; Li ZH; Zhang S; Rong Y; Yang GH; Fang-Zheng
    Gene; 2019 Jan; 683():35-40. PubMed ID: 30292871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Luo JP; Wang J; Huang JH
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34405225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.